NICE recommends NHS use of new melanoma drugs
Advanced melanoma sufferers should be given two life-prolonging drugs by the NHS, according to draft guidance from health watchdog NICE.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
- Customised email alerts straight to your inbox (30+ alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units